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Despite the formidable mutational capacity and sequence diversity of HIV-1, evidence suggests that viral evolution in
response to specific selective pressures follows generally predictable mutational pathways. Population-based analyses
of clinically derived HIV sequences may be used to identify immune escape mutations in viral genes; however, prior
attempts to identify such mutations have been complicated by the inability to discriminate active immune selection
from virus founder effects. Furthermore, the association between mutations arising under in vivo immune selection
and disease progression for highly variable pathogens such as HIV-1 remains incompletely understood. We applied a
viral lineage-corrected analytical method to investigate HLA class I-associated sequence imprinting in HIV protease,
reverse transcriptase (RT), Vpr, and Nef in a large cohort of chronically infected, antiretrovirally naı ¨ve individuals. A
total of 478 unique HLA-associated polymorphisms were observed and organized into a series of ‘‘escape maps,’’ which
identify known and putative cytotoxic T lymphocyte (CTL) epitopes under selection pressure in vivo. Our data indicate
that pathways to immune escape are predictable based on host HLA class I profile, and that epitope anchor residues
are not the preferred sites of CTL escape. Results reveal differential contributions of immune imprinting to viral gene
diversity, with Nef exhibiting far greater evidence for HLA class I-mediated selection compared to other genes.
Moreover, these data reveal a significant, dose-dependent inverse correlation between HLA-associated polymorphisms
and HIV disease stage as estimated by CD4
þ T cell count. Identification of specific sites and patterns of HLA-associated
polymorphisms across HIV protease, RT, Vpr, and Nef illuminates regions of the genes encoding these products under
active immune selection pressure in vivo. The high density of HLA-associated polymorphisms in Nef compared to other
genes investigated indicates differential HLA class I-driven evolution in different viral genes. The relationship between
HLA class I-associated polymorphisms and lower CD4
þ cell count suggests that immune escape correlates with disease
status, supporting an essential role of maintenance of effective CTL responses in immune control of HIV-1. The design
of preventative and therapeutic CTL-based vaccine approaches could incorporate information on predictable escape
pathways.
Citation: Brumme ZL, Brumme CJ, Heckerman D, Korber BT, Daniels M, et al. (2007) Evidence of differential HLA class I-mediated viral evolution in functional and accessory/
regulatory genes of HIV-1. PLoS Pathog 3(7): e94. doi:10.1371/journal.ppat.0030094
Introduction
Genetic variation within the highly polymorphic human
leukocyte antigen (HLA) class I region contributes to diversity
of pathogen recognition by cytotoxic T lymphocytes (CTLs)
[1], and acts as a selective force shaping viral evolution within
an infected host [2–6] through selection of mutations that
allow the virus to escape recognition by HLA-restricted CTLs
[5,7–9]. Immune escape may also represent a signiﬁcant force
shaping viral evolution at the population level through an
HLA ‘‘imprinting effect,’’ in which escape mutations selected
in the context of common HLA class I alleles may become
predominant in the circulating viral population if they do not
revert upon transmission to new hosts [2,10,11].
One of the major challenges to HIV vaccine design is the
extensive worldwide sequence diversity of this pathogen,
fueled in part by the extreme mutational capacity of the virus
[12]. However, despite this considerable diversity, evidence
indicates that there are constraints on viral evolution
[2,13,14], and that escape in response to speciﬁc immune
selective pressures (similar to escape from drug selective
pressures [15]) follows broadly predictable mutational pat-
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and patterns of immune escape in clinical HIV-1 isolates will
further our understanding of how immune selection contrib-
utes to viral diversity [2,16] and will also identify speciﬁc viral
regions under active immune selection pressure, thus
providing information relevant to the selection of candidate
immunogens for an HIV-1 vaccine.
Improvements in DNA sequencing technologies and the
availability of large cohorts of HIV-1 infected individuals now
allow us to employ population-based genetic association
approaches to identify viral amino acids (aa) under active
immune selection pressure in vivo [2]; however, methodo-
logical challenges associated with identifying such mutations
are now recognized [16]. Moore et al. [2] were the ﬁrst to
identify HLA-class I-associated polymorphisms across codons
20–227 of HIV-1 reverse transcriptase (RT) in a large
clinically derived dataset using a Chi-squared association
approach, thus providing evidence for HLA class I-mediated
viral evolution on a population level. However, the applica-
tion of standard statistical tests is inappropriate for the
analysis of viral isolates with a shared phylogenetic history,
since descent from a common ancestor means that viral
sequences may not be treated as statistically independent
entities [17]. Speciﬁcally, a cause for concern is the
application of standard statistical methods to identify HLA-
associated viral polymorphisms in cohorts comprising indi-
viduals of diverse genetic backgrounds (sampled from
populations with differential HLA allele distributions) in-
fected with heterogeneous viral strains. In this case, standard
statistical approaches such as the Chi-squared test may
identify confounding associations between strain- or line-
age-speciﬁc viral polymorphisms and speciﬁc HLA alleles that
are over-represented in subpopulations of individuals har-
boring infections with those strains. In this case, the observed
‘‘HLA-associated polymorphism’’ is not evidence of active
HLA-mediated immune selection. Rather, the association is
simply a statistical correlation between possession of a
particular HLA allele observed among persons of a particular
ethnic background, and a lineage-speciﬁc viral polymor-
phism, arising as a result of descent from a common ancestor
(‘‘founder effect’’) [16]. The use of population-based, viral
lineage-corrected analyses, such as those recently developed
by Bhattacharya et al. [16], are therefore essential in order to
accurately identify sites of active immune selection in the
genomes of sequence-diverse pathogens such as HIV-1.
In addition, although there is clear evidence supporting
HIV-1 adaptation to HLA class I-mediated CTL selection
pressure from an evolutionary standpoint [2–5], the relevance
of immune escape to clinical HIV disease progression
remains unclear, due in part to the fact that many studies
have focused small numbers of participants and/or escape
within a limited number of HLA-restricted CTL epitopes in
the viral genome [3–6,18–20]. Furthermore, no studies to date
have linked HIV disease progression to HLA-associated
polymorphisms corrected for lineage effects. Here we
identify lineage-corrected [16] HLA class I-associated poly-
morphisms across select functional and accessory/regulatory
HIV-1 genes in a cross-sectional analysis of a large cohort of
chronically infected, treatment-naı ¨ve individuals, and inves-
tigate the relationship between these polymorphisms and
clinical markers of HIV disease.
Results
A large, well-characterized cohort of chronically HIV-1
infected, antiretroviral drug-naı ¨ve individuals from British
Columbia, Canada [21], for whom HLA class I typing and HIV
RNA genotyping of select functional and accessory/regulatory
genes were performed, was used to identify HLA class I allele-
associated viral polymorphisms across a 499 aa fragment
spanning protease and most of RT p51 (n ¼ 532 successfully
genotyped), 96 aa of Vpr (n¼425), and 206 aa of Nef (n¼686).
HLA class I allele-associated viral polymorphisms were
identiﬁed using analytical approaches described in [16],
which feature a correction for viral lineage effects by
adjusting for phylogenetic relationships between sequences
[16], and a correction for multiple comparisons using a q-
value approach [22], which sets the false-discovery rate (20%
with q , 0.2) among signiﬁcant associations. The level of
variation at single residues in protease, RT, Vpr, and Nef
ranged from 0% to maxima of 50%, 57%, 73%, and 77%
respectively (Figure 1), while the mean pairwise amino acid
identity for these same genes (calculated as the percentage of
codons exhibiting identical amino acids for each pairwise
combination of sequences) was 92.9%, 95.3%, 89.0%, and
Figure 1. Differential Density of HLA Class I-Associated Viral Polymorphisms across HIV Protease, Reverse Transcriptase, Vpr, and Nef
Polymorphism maps display the percentage amino acid variation over protease (A), reverse transcriptase (B), Vpr (C), and Nef (D). Red 3 symbols
indicate codons at which at least one significant HLA-associated polymorphism was observed with q , 0.2.
doi:10.1371/journal.ppat.0030094.g001
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Author Summary
One of the greatest challenges facing HIV-1 vaccine design today is
the formidable capacity of the virus for mutation and adaptation, a
characteristic that has contributed to the extensive worldwide
genetic variability of HIV-1 strains observed today. On an individual
basis, evolutionary selective pressures imposed by each infected
person’s unique immune response results in the selection and
outgrowth of viral ‘‘escape’’ mutants capable of evading immune
recognition, while on a population basis, complex evolutionary
selective pressures imposed by the highly polymorphic genes of the
human immune system shape HIV-1 diversity on a global level.
Making sense of the seemingly infinite complexity of HIV immune
escape is of paramount importance in our goal of developing a
successful HIV vaccine. The current study uses cutting-edge
statistical methods to identify specific sites and patterns of human
leukocyte antigen (HLA) class I-restricted escape mutations in
various HIV genes. Researchers summarize their findings in the
form of ‘‘immune escape maps,’’ which highlight the differential
contribution of immune imprinting to HIV genetic diversity, as well
as identify specific sites in the viral genome under active immune
selection pressure. Results from the present study contribute to our
understanding of how human immune selective pressure contrib-
utes to variation in different HIV genes, and could help inform the
development of HIV vaccines that take into consideration viral
diversity.PLoS Pathogens | www.plospathogens.org July 2007 | Volume 3 | Issue 7 | e94 0915
HLA-Mediated Evolution in HIV83.1%, respectively, indicating typical intrasubtype levels of
HIV sequence diversity in this cohort of relatively homoge-
neous subtype distribution (97.5% HIV-1 subtype B).
It is important to note that the phylogenetically corrected
methods for identiﬁcation of HLA-associated viral poly-
morphisms developed by Bhattacharya et al. [16] do more
than simply correct for confounding due to HIV intersubtype
(or interclade) variation. Even among clade-homogeneous
datasets, ‘‘subclade’’ lineage-speciﬁc effects may yield con-
founding associations with HLA alleles, especially if the
cohort is composed of subpopulations with differential HLA
allele distributions. Indeed, there was clear evidence of
phylogenetic subclusters within subtype B sequences in this
cohort (Figure S1).
We therefore compared phylogenetically corrected meth-
ods to a simple uncorrected test (simple Fisher), and found
that even in this predominantly subtype B-infected cohort,
HLA-associated polymorphisms identiﬁed using phylogeneti-
cally corrected methods had higher fractions of associations
that could be independently validated by immunological data
than those deﬁned using a simple Fisher exact test (unpub-
lished data). An example of a case in which an apparent HLA-
associated polymorphism identiﬁed using a simple Fisher
exact test represents an artifact of the phylogenetic tree is
illustrated in Figure S1. In this analysis, therefore, we report
only HLA-associated polymorphisms deﬁned using phylog-
eny-based methods [16].
Application of the viral lineage-corrected method [16]
yielded a total of 478 unique HLA allele-associated viral
polymorphisms with q , 0.2 across the genes investigated
(Table S1). These occurred at nine (9%), 28 (7%), 12 (12.5%),
and 84 (41%) unique codons in protease, RT, Vpr, and Nef,
respectively, highlighting a dramatic variation in HLA-
associated imprinting across HIV-1 genes (Figure 1). HLA-B
alleles accounted for half (241 of 478; 50.4%) of the total
number of HLA-associated polymorphisms, while HLA-A and
C alleles accounted for 112 (23.4%) and 125 (26.2%),
respectively.
Previous studies have validated the application of such
genetic association analyses of large clinically derived data-
sets in order to identify HLA-restricted CTL escape muta-
tions selected in vivo [16]. Knowing that with q , 0.2, about
20% of identiﬁed HLA-associated polymorphisms will rep-
resent false-positive results, we set about classifying the 478
identiﬁed polymorphisms into putative true-positive or false-
positive results based on the strength of independent
biological evidence supporting each polymorphism as an
escape-associated mutation. The highest level of biological
support was assigned to HLA-associated polymorphisms
falling within or proximal to (6 3 aa) a published CTL
epitope [23] restricted by that particular HLA allele, thereby
supporting these associations as in vivo-selected mutations
directly or indirectly affecting MHC binding, T cell receptor
recognition and/or intracellular peptide processing [24–26].
A second level of support was assigned to those associations
falling within or similarly proximal to putative/novel HLA-
restricted epitopes, identiﬁed by scanning the cohort
consensus sequence for HLA-restricted epitope anchor
residue motifs using two independent bioinformatic tools
(MotifScan [Los Alamos National Laboratory], http://www.hiv.
lanl.gov/content/immunology/motif_scan/motif_scan; and
Epipred [Microsoft Research], http://atom.research.
microsoft.com/bio/epipred.aspx).
To provide further biological support for these associa-
tions we drew upon an independent cohort of 372 HIV-1
infected individuals screened for in vitro HLA-restricted,
CTL-mediated interferon-gamma (IFN-c) responses against a
set of overlapping HIV-1 subtype B consensus peptides
spanning the entire viral proteome using the IFN-c enzyme-
linked immunosorbent spot assay (ELISpot) [27], in order to
identify HLA class I alleles signiﬁcantly associated with CTL-
mediated IFN-c production in response to stimulation with
consensus HIV peptides (see Methods). HLA allele-associated
polymorphisms mapping within a signiﬁcantly reactive HLA
allele/HIV consensus peptide pair were identiﬁed as potential
escape-associated mutations to known or novel HLA-
restricted CTL epitopes.
Finally, we grouped together HLA allele-speciﬁc associa-
tions clustering within these epitopes or motifs, and paired
together alleles in linkage disequilibrium (Table S2) associ-
ated with the same HIV polymorphism(s), to create a series of
immune escape maps capturing the minimum number of
HLA-restricted epitopes and/or motifs required to explain
the data (Figures 2–5). Associations that did not map within a
known epitope or motif, and were not supported by ELISpot
data or attributable to HLA allele linkage, were listed in a
separate map (Figure 6).
After pairing together linked alleles, approximately 35% of
codons in protease, RT, Vpr, and Nef exhibiting HLA-
associated polymorphisms mapped inside (n ¼ 77; 81%) or
within 6 3a a( n ¼ 18; 19%) of a published CTL epitope
speciﬁc to that HLA allele (Figures 2 and 3). Signiﬁcant
associations were collapsed into two categories based on the
direction of the HLA selection pressure: amino acids
enriched in the presence of a speciﬁc allele (positive or
‘‘escape’’ correlations, presumably representing the escape
variant for that allele), and amino acids depleted in the
presence of a speciﬁc allele (negative or ‘‘reversion’’
correlations, presumably representing the immunologically
susceptible or ‘‘wild-type’’ form for that allele, and also
representing the amino acid to which the residue will likely
revert to upon transmission an individual lacking that allele).
Overall, the majority of HLA-associated polymorphisms (58%
of epitope-supported associations) represent negative (‘‘re-
version’’) correlations (p ¼ 0.002). Note that detection of a
‘‘reversion’’ correlation in the absence of an associated
‘‘escape’’ correlation may arise in the case where a speciﬁc
allele selects for multiple amino acids at a given position,
creating a situation where there may be sufﬁcient statistical
power to detect the ‘‘reversion’’ correlation but not to
identify all possible escape variants.
A considerable number of codons exhibit multiple HLA
associations, particularly in Nef. A total of 57 multiple
associations were observed, with 2, 6, 3, and 46 occurring
across protease, RT, Vpr, and Nef, respectively. In 23 of these
57 cases (for example, Nef codons 81 and 135), the same amino
acid represents an escape variant for one HLA allele, but the
susceptible form for another, highlighting a ‘‘tug-of-war’’ of
differential HLA selective pressures contributing to popula-
tional HIV sequence diversity at speciﬁc codons.
There were dramatic differences in the number of HLA-
associated polymorphisms across the genes investigated. Not
only did Nef exhibit a much higher density of epitope-
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HLA-Mediated Evolution in HIVFigure 2. Epitope Support Maps: HLA-Associated Polymorphisms Mapping within or Directly Proximal to Published HLA-Restricted CTL Epitopes in
Protease/Reverse Transcriptase and Vpr
HLA-associated polymorphisms occurring within or directly proximal (6 3 aa) to published HLA-restricted CTL epitopes in protease/RT and Vpr are
shown. Polymorphisms associated with the same HLA allele(s) occurring within, or directly proximal to (6 3 aa) published HLA-restricted epitope
boundaries are boxed together in yellow. The published epitope sequence (and associated HLA) is indicated above the epitope boundary arrow. If
associations within the same epitope boundaries are ascribed to several linked HLA alleles, the HLA that is known to present the epitope is indicated
next to it. Red (‘‘escape’’) amino acids indicate positive correlations (amino acids that are enriched in the presence of a specific HLA allele). Thus,
‘‘escape’’ (red) amino acids presumably reflect the escape variant specific for that HLA allele. Blue (‘‘reversion’’) amino acids indicate negative
correlations, where the presence of a specific HLA allele is associated with the absence of a particular amino acid at a specific position—or, likewise,
where the absence of the specific HLA allele is associated with the presence of this amino acid. Thus, ‘‘reversion’’ (blue) amino acids presumably reflect
the immunologically susceptible form specific for that HLA allele, and the amino acid to which the sequence may revert upon transmission to an HLA-
unmatched host. Underlined associations indicate potential HLA anchor residue sites. Proximal associations (within 6 3 aa of epitope boundaries) are
marked with an asterisk (*). Associations additionally supported by functional IFN-c (ELISpot) data are indicated in green.
doi:10.1371/journal.ppat.0030094.g002
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HLA-Mediated Evolution in HIVFigure 3. Epitope Support Map: HLA-Associated Polymorphisms Mapping within or Directly Proximal to Published HLA-Restricted CTL Epitopes in Nef
HLA-associated polymorphisms occurring within or directly proximal (6 3 aa) to published HLA-restricted CTL epitopes in Nef are shown.
Polymorphisms associated with the same HLA allele(s) occurring within, or directly proximal to (6 3 aa) published HLA-restricted epitope boundaries
are boxed together in yellow. The published epitope sequence (and associated HLA) is indicated above the epitope boundary arrow. If associations
within the same epitope boundaries are ascribed to several linked HLA alleles, the HLA that is known to present the epitope is indicated next to it. Red
(‘‘escape’’) amino acids indicate positive correlations (amino acids that are enriched in the presence of a specific HLA allele). Thus, ‘‘escape’’ (red) amino
acids presumably reflect the escape variant specific for that HLA allele. Blue (‘‘reversion’’) amino acids indicate negative correlations, where the
presence of a specific HLA allele is associated with the absence of a particular amino acid at a specific position—or, likewise, where the absence of the
specific HLA allele is associated with the presence of this amino acid. Thus, ‘‘reversion’’ (blue) amino acids presumably reflect the immunologically
susceptible form specific for that HLA allele, and the amino acid to which the sequence may revert upon transmission to an individual lacking that HLA
allele. Underlined associations indicate potential HLA anchor residue sites. Proximal associations (within 6 3 aa of epitope boundaries) are marked with
an asterisk (*). Associations additionally supported by functional IFN-c (ELISpot) data are indicated in green
doi:10.1371/journal.ppat.0030094.g003
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HLA-Mediated Evolution in HIVFigure 4. Motif Support Maps: HLA-Associated Polymorphisms Mapping within or Directly Proximal to HLA-Restricted CTL Epitope Motifs in Protease/
Reverse Transcriptase and Vpr
HLA-associated polymorphisms occurring within or directly proximal to (6 3 aa) known HLA-restricted epitope anchor residue motifs in protease/RT
and Vpr are shown. Polymorphisms associated with the same HLA allele(s) occurring within or directly proximal to (6 3 aa) of HLA-restricted epitope
anchor residue motifs are boxed together in yellow. Predicted epitopes (where available) are indicated above the epitope boundary arrow, while
HLA-restricted epitope motif boundaries are simply marked by their corresponding HLA association. Where multiple overlapping motifs were present,
only the most commonly observed one (based on analysis of individual sequences) is indicated. Linked alleles are indicated in brackets, and in ranked
order based on p-value of the association. Red (‘‘escape’’) amino acids indicate positive correlations (amino acids that are enriched in the presence of
a specific HLA allele thus presumably represent escape variants). Blue (‘‘reversion’’) amino acids indicate negative correlations, where the presence of
a specific HLA allele is associated with the absence of a particular amino acid at a specific position—and vice versa—in this case, the amino acid
presumably reflects the immunologically susceptible form specific for that HLA allele. Underlined associations indicate potential HLA anchor residue
sites. Proximal associations (within 6 3 aa of epitope boundaries) are marked with an asterisk (*). Associations supported by functional IFN-c
(ELISpot) data are indicated in green. Where an association is supported solely by ELISpot data, but no predicted epitope or motif, the arrow and lines
are all green.
doi:10.1371/journal.ppat.0030094.g004
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HLA-Mediated Evolution in HIVFigure 5. Motif Support Maps: HLA-Associated Polymorphisms Mapping within or Directly Proximal to HLA-Restricted CTL Epitope Motifs in Nef
HLA-associated polymorphisms occurring within or directly proximal to (6 3 aa) known HLA-restricted epitope anchor residue motifs in Nef are shown.
Polymorphisms associated with the same HLA allele(s) occurring within or directly proximal to (6 3 aa) of HLA-restricted epitope anchor residue motifs
are boxed together in yellow. Predicted epitopes (where available) are indicated above the epitope boundary arrow, while HLA-restricted epitope motif
boundaries are simply marked by their corresponding HLA association. Where multiple overlapping motifs were present, only the most commonly
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HLA-Mediated Evolution in HIVsupported associations compared to protease/RT and Vpr,
but the escape patterns also tended to be more complex in
Nef than in other genes. A total of 53% of escaping epitopes
in Nef exhibited HLA-associated polymorphisms at multiple
positions within the epitope, compared with 12% and 0% in
protease/RT and Vpr, respectively (p ¼ 0.004). Similarly,
epitope-proximal associations (occurring within 3 aa of a
published epitope) were also observed more frequently in Nef
(n ¼ 16 [22%]) while occurring only relatively rarely in
protease/RT/Vpr (total n ¼ 2 [9%]), although this did not
achieve statistical signiﬁcance (p ¼ 0.2).
Overall, HLA-associated polymorphisms were observed
with relatively equal frequency across all positions within
published HLA-restricted epitopes. There was no statistically
signiﬁcant enrichment for HLA-associated polymorphisms at
anchor residues (generally deﬁned as epitope residues 2 and
C-terminal with some exceptions [28,29]) over other residues
in Nef (p ¼ 0.7) or protease/RT/Vpr (p . 0.1) suggesting that
amino acid changes potentially affecting peptide binding to
HLA class I molecules are not a favored mechanism of escape.
We organized a further ;50% of the identiﬁed associations
into ‘‘motif-support’’ maps (Figures 4 and 5) that grouped
HLA-associated polymorphisms within HLA-restricted epit-
ope anchor residue motifs identiﬁed by scanning the cohort
consensus sequence. Based on evidence that HLA-associated
polymorphisms identiﬁed in genetic association studies
predict the location of previously uncharacterized epitopes
[16], we would expect that a substantial proportion of motif-
supported associations represent escape mutations within
novel epitopes, a hypothesis supported by the fact that many
motif-supported associations (40%, 31%, 22%, and 19% in
protease, RT, Vpr, and Nef, respectively) are substantiated by
in vitro IFN-c ELISpot responses to HIV-speciﬁc consensus
peptides containing these motifs. Consistent with observa-
tions drawn from the epitope-support maps (Figures 2 and 3),
the majority (63%) of associations in the motif-support maps
represent ‘‘reversion’’ associations, with a much more
complex pattern of escape observed in Nef compared to
protease/RT/Vpr.
The remaining ;15% of HLA-associated polymorphisms
did not map to known epitopes and were unlikely to lie
within or proximal to novel epitopes as suggested by in vitro
IFN-c ELISpot responses or bioinformatic motif scans (Figure
6). Although these proportions are consistent with the false-
discovery rate of ;20% (q , 0.2), lack of biological support
cannot be used to deﬁnitively categorize these as ‘‘false-
positive’’ associations in any particular case. In some cases,
these may represent processing escape mutations occurring
distant from the epitope site, compensatory mutations,
unusual epitopes, or other factors. Similarly, HLA-associated
polymorphisms mapping within an HLA-matched epitope or
motif are likely highly enriched for mutations directly or
indirectly conferring immune escape, but likely contain
smaller numbers of false-positive associations as well.
Although there is clear evidence documenting the selection
of escape variants over the course of HIV infection [3–5,7–9],
the clinical signiﬁcance of immune escape remains incom-
pletely understood [18–20]. Moore et al. reported a signiﬁcant
association between HLA-associated polymorphisms and
plasma viral load [2]; however, no studies to date have linked
lineage-corrected HLA-associated polymorphisms with
markers of disease progression on a population basis. We
therefore investigated correlations between the presence of
HLA-associated polymorphisms and clinical status in chronic
untreated infection as measured by pretherapy CD4
þ cell
number and plasma viral load. In order to adopt the most
conservative deﬁnition of ‘‘escape,’’ the primary analysis was
restricted to those amino acid associations mapping inside or
within 6 3 aa of a known HLA-restricted CTL epitope
(Figures 2 and 3). A signiﬁcant inverse dose–dependent
relationship was observed between the median pretherapy
CD4
þ cell count and the number of epitope-associated
polymorphisms observed in protease/RT (p ¼ 0.006), Vpr (p
¼ 0.01), and Nef (p ¼ 0.008) (Figure 7). A trend was observed
between accumulation of epitope-associated polymorphisms
in protease/RT (but not other proteins) and higher prether-
apy viral load (p ¼ 0.06 [unpublished data]). The dose-
dependent association between epitope-associated polymor-
phisms and lower CD4
þ cell counts supports the ability of
large genetic association studies to identify biologically
relevant in vivo CTL escape-associated mutations, but more
importantly, supports a clinically relevant link between
immune escape and HIV disease progression.
Note that the observed association between HLA-associ-
ated polymorphisms and lower CD4
þ cell count is speciﬁc to
HLA-associated polymorphisms mapping within or near
published epitopes, and not simply a general association
between viral mutations and HIV clinical status. In a
secondary analysis we investigated correlations between the
presence of motif-associated (Figures 4 and 5) and unsup-
ported (Figure 6) polymorphisms and clinical parameters. A
nonsigniﬁcant trend (p ¼ 0.07) was observed between
accumulation of motif-associated polymorphisms in pro-
tease/RT (but not other proteins) and lower median CD4
þcell
counts, while no signiﬁcant association was observed between
clinical parameters and the presence of biologically unsup-
ported associations, consistent with a stepwise enrichment
for false-positives among associations in these categories.
Discussion
The present study represents to our knowledge the largest
population-based investigation of HLA class I-mediated
imprinting on HIV sequence to date, as well as the ﬁrst
observed one (based on analysis of individual sequences) is indicated. Linked alleles are indicated in brackets, and in ranked order based on p-value of
the association. Red (‘‘escape’’) amino acids indicate positive correlations (amino acids that are enriched in the presence of a specific HLA allele thus
presumably represent escape variants). Red dashes indicate positions where the presence of the HLA is associated with deletion of the amino acid at
that position. Blue (‘‘reversion’’) amino acids indicate negative correlations, where the presence of a specific HLA allele is associated with the absence of
a particular amino acid at a specific position—and vice versa—in this case, the amino acid presumably reflects the immunologically susceptible form
specific for that HLA allele. Underlined associations indicate potential HLA anchor residue sites. Proximal associations (within 6 3 aa of epitope
boundaries) are marked with an asterisk (*). Associations supported by functional IFN-c (ELISpot) data are indicated in green. Where an association is
supported solely by ELISpot data, but no predicted epitope or motif, the arrow and lines are all green.
doi:10.1371/journal.ppat.0030094.g005
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of a functional, accessory and regulatory gene. Results
identify viral polymorphisms selected in vivo in context of a
wide array of class I alleles. The conﬁrmation of the B*1501-
associated polymorphism at protease codon 93 reported by
Bhattacharya et al. [16] and several reported by Moore et al.
[2] in RT suggest that immune escape patterns in HIV-1
subtype B are consistent across the globe. The conﬁrmation
of several functionally veriﬁed CTL escape mutations
previously observed in clinically derived isolates (including
escape at residues 2, 8, 2, and 5 of the HLA-B*57 restricted
IW9-RT [13,30], B*51-restricted TI8-RT [31], A*24-restricted
RF10-nef [32], and B*08-restricted FL8-nef [5] epitopes,
respectively) conﬁrm the utility of genetic association studies
to identify escape variants commonly selected in vivo. Taken
together, results provide proof of principle that population-
based approaches could complement smaller functional
studies by providing a whole-gene or whole-virus picture of
immune escape.
Results of this large-scale, multigene analysis reveal
dramatically different levels of HLA-associated polymor-
phisms across HIV proteins, with a previously unreported,
extraordinary density and complexity of HLA-associated
polymorphisms in Nef. Nef exhibits considerable sequence
diversity and thus may exhibit higher levels of mutational
plasticity in response to selective pressures compared to
genes exhibiting structural (e.g., Gag) or functional (e.g.,
protease/RT) constraints; however it is important to note that
protease (and to a lesser extent RT) exhibit extensive
mutational capacity under antiretrovirally mediated selection
pressure [15], suggesting that mutational constraints on
functional genes are unlikely to fully account for the relative
paucity of HLA-associated polymorphisms across these
regions. Rather, results are consistent with the density of
CTL epitopes across these regions, as well as the relative
immunogenicity of these proteins over the course of
infection [27,33]. Limited data from longitudinal studies
suggest that CTL escape mutations in Nef are selected earlier
in infection [33,34], and thus, in a population of chronically
infected individuals, one may expect a large burden of Nef
escape mutations to have already accumulated. Note that, in
the current study, Nef sequences were available for a larger
number of participants, thus potentially increasing power to
detect signiﬁcant associations.
These data are also relevant to CTL-based HIV vaccine
design. First and foremost, the analysis of clinically derived
datasets identiﬁes viral epitopes under active immune
selection pressure, thus identifying in vivo immunogenic
viral targets. The fact that we observed such a large number
of HLA-associated polymorphisms, including many instances
of speciﬁc codons apparently under diametrically opposed
HLA-selective pressures (an observation consistent with
Iversen et al. [35]), provide some evidence against the
complete disappearance of all active viral epitopes under
the HLA ‘‘imprinting hypothesis’’ (which states that escape
mutations selected in response to the most common HLA
alleles may become ﬁxed in the circulating viral population
[2,10], thus resulting in a potential loss of CTL responses to
these epitopes and rendering them inappropriate as candi-
date immunogens). Taken together with evidence supporting
rapid reversion of escape mutations after transmission to a
new host [36], and the fact that escape mutations in one
individual may represent the susceptible form in another [16],
the ‘‘HLA imprinting effect’’ is unlikely to result in the
creation of an immunologically refractive circulating viral
population by eliminating all active CTL epitopes in this
population. Rather, selection pressures mediated by diverse
HLA class I alleles in HIV-1 infected populations appear to be
actively contributing to viral diversity thus preserving a
substantial number of immunologically active epitopes in the
circulating population. These active epitopes, most notably
those which exhibit the ‘‘push-and-pull’’ of diametrically
opposed HLA selection pressures, could perhaps be incorpo-
rated into a CTL-based HIV-1 vaccine strategy.
The locations of HLA-associated polymorphisms relative to
known or predicted HLA-appropriate epitopes revealed no
statistically signiﬁcant enrichment for mutations at epitope
anchor residues versus other positions. Theoretically, if the
predominant mechanism of CTL escapes were abrogation of
peptide-MHC binding through anchor residue mutation, a
polyvalent vaccine approach may have little merit. However,
these observations, combined with previous documentation
of de novo T cell responses arising in response to escape
variants [37], strongly support the utility of incorporating
viral sequence variation into immunogen design.
Given the adaptable nature of the CTL response [37],
combined with the fact that the majority of reports of CTL
escape to date have focused on small numbers of individuals
and/or a select few epitopes [3–6,18–20,30–32,35], it is not
surprising that the clinical consequences of CTL escape
remain incompletely understood. Some studies report an
association between selection of escape variants and loss of
viremia control [20,38] and disease progression [6,18];
however, this does not seem to equally apply to all CTL
epitopes [35,39]. Here we observe a signiﬁcant, dose-depend-
ent inverse relationship between HLA-associated mutations
within published epitopes in functional and accessory/
regulatory genes and lower CD4
þ cell counts in chronic
untreated HIV infection, thus supporting a link between
presence of escape mutations and HIV disease status.
Although detection of escape mutations indeed preceded a
loss of immune control in previous case reports [6,18], it is
important to note that the cross-sectional nature of the
current study precludes any inferences regarding cause and
effect. Likely, a longer duration of infection (among those
with lower CD4
þ cell counts in this cohort) may have
facilitated the accumulation of CTL escape variants, a
hypothesis we were unable to investigate, because serocon-
Figure 6. No Support Maps: HLA-Associated Polymorphisms in Reverse Transcriptase, Vpr, and Nef That Do Not Map within Known or Putative Epitopes,
and Are Not Supported by Functional IFN-c (ELISpot) Data
Associations displayed on this map are likely to be highly enriched for the expected proportion of false-positives (20% with q , 0.2). However, we
cannot rule out the possibility that these may represent processing escape mutations occurring distant from the epitope site, compensatory mutations,
unusual epitopes, or other factors. Note that no ‘‘unsupported’’ HLA-associated polymorphisms were observed in HIV protease.
doi:10.1371/journal.ppat.0030094.g006
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this analysis include the inherent limitations associated with
the use of a single CD4
þcell measurement in a cross-sectional
study design, the lack of longitudinal HIV sequence data, as
well as the fact that the cohort represents a group of
individuals referred for antiretroviral treatment, and thus
may be biased toward more rapid progression to disease.
Despite these limitations, our ﬁndings support those of
Moore et al. [2] who reported that HLA-associated poly-
morphisms in RT predicted plasma viral load (CD4
þ cell
counts were not investigated). At ﬁrst, results appear
inconsistent with those of Iversen et al. [35] who reported
higher viral loads in patients with efﬁcient CTL selection;
however, results may be reconciled by the fact that the
previous study [35] investigated clinical correlates of escape
to a single HLA-restricted epitope, whereas the current study
evaluates HLA-associated polymorphisms across multiple
genes. Ideally, however, the relationship between selection
of HLA-associated escape mutations and HIV disease
progression should be addressed in an unbiased, longitudinal
cohort study of untreated HIV-1 seroconverters for whom
infection dates, viral loads and CD4
þ T cell setpoints, and
rates of disease progression are known.
Although a systematic in vitro characterization of novel
CTL epitopes was beyond the scope of this manuscript, the
observation that a substantial number of motif-associated
polymorphisms are supported by HLA-restricted, peptide-
speciﬁc IFN-c responses in an ELISpot assay suggest that they
represent escape mutations within uncharacterized epitopes
[16]. As the locations of published epitopes tend to be biased
toward conserved regions (due to the historic use of
consensus or reference strains to construct peptide libraries),
the ‘‘motif maps’’ could complement traditional epitope
mapping by identifying epitopes located in more variable
regions.
After controlling for the potentially confounding effects of
viral lineage [16], strong evidence for HLA class I-mediated
selection is observed across functional and accessory/regu-
latory HIV-1 genes, with up to 40% of residues in some HIV
proteins (Nef, for example) exhibiting evidence for HLA-
restricted immune selection. Our results thus conﬁrm an
active and substantial contribution of human immunogenetic
selection pressure on viral evolution [2] and underscore the
importance of understanding how HLA class I diversity drives
HIV diversity. The observed correlation between the pres-
ence of HLA-associated CTL escape mutations and lower
CD4
þcell counts supports the hypothesis that maintenance of
effective CTL responses plays an important role in immune
control of HIV infection, although further research in
additional cohorts is needed. The observation that epitope
anchor residue mutation appears not to be the predominant
mechanism of CTL escape supports the incorporation of HIV
sequence diversity in the development of preventative and
therapeutic CTL-based vaccine approaches.
Methods
Study participants: The British Columbia HOMER cohort. In
British Columbia (BC), antiretroviral drugs are distributed free of
charge to HIV-infected individuals through a centralized drug
treatment program (for details, see [21]). The HAART Observational
Medical Evaluation and Research (HOMER) cohort is an open cohort
comprising all HIV-infected, antiretroviral-naı ¨ve adults who initiated
HAART since August 1996 (n . 2,200 individuals enrolled to date). A
subset of HOMER, comprising all treatment-naı ¨ve individuals who
initiated HAART in BC between August 1996 and September 1999 (n
¼ 1,191) has been described in detail previously [21]. Participants in
the current cross-sectional study represent a nonrandom subset (n ¼
765; 64%) of these 1,191 individuals at baseline (prior to initiation of
HAART) included based on the availability of a peripheral blood
Figure 7. Inverse Dose-Response Relationship between Accumulation of
Epitope-Associated Escape Mutations in Protease/Reverse Transcriptase,
Vpr, and Nef and CD4
þ Cell Count in Chronic Untreated HIV Infection
A significant inverse dose-response relationship is observed between the
presence of epitope-associated escape mutations in protease/RT (A), Vpr
(B), and Nef (C) and CD4
þ cell count in chronic untreated HIV infection.
Escape mutations were defined as all significant HLA/HIV associations
which mapped within or proximal to (6 3 aa) known CTL-restricted
epitopes (listed in Figures 2 and 3). Analysis was restricted to participants
able to exhibit ‘‘escape,’’ i.e., those possessing at least one HLA allele
featured in Figures 2 and 3 (for each gene investigated). Linked alleles
were removed to avoid double counting of associations. Diamonds and
bars represent median and interquartile ranges, respectively, of
pretherapy CD4
þ cell count for each of the associated escape strata.
Overall p-value obtained using the Kruskal-Wallis test. Significant (p ,
0.05) pairwise associations are indicated by brackets.
doi:10.1371/journal.ppat.0030094.g007
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of those included (n ¼ 765) and excluded (n ¼ 426) reveals no
signiﬁcant differences in pretherapy CD4
þ cell count (280 cells/mm
3);
however, those included had slightly lower pretherapy plasma viral
load (pVL) (median 5.07 versus 5.15 log10 copies HIV RNA/ml, p ¼
0.03), were on average slightly older (median 37.2 versus 36.5 y, p ¼
0.02), and were more likely to be male (median 88% versus 77% male,
p , 0.0001) than those excluded. CD4
þ cell count, plasma viral load,
and HIV genotype data for each participant represent the latest pre-
therapy measurement collected within 180 d prior to HAART
initiation. Ethical approval for this study was granted by the
Providence Health Care/University of British Columbia Research
Ethics Board.
Determination of baseline HIV gene sequences and viral subtypes.
HIV RNA was extracted from a single pre-therapy (‘‘baseline’’) plasma
sample using the QIAGEN (http://www.qiagen.com) viral RNA kit
using a BioRobot 9600/9604 or extracted manually using guanidi-
nium-based buffer followed by isopropanol/ethanol washes. The HIV
protease (codons 1–99, HXB2 nt 2253–2549), RT (codons 1–400, or
for ;25% of sequences codons 1–240 only; nt 2550–3749 or 2550–
3269, respectively), Vpr (codons 1–96; nt 5559–5847), and Nef (codons
1–206; nt 8797–9414) were ampliﬁed using nested RT-PCR, and
‘‘bulk’’ sequenced in both the 59 and 39 directions on an ABI 3700 or
3100 (http://www.appliedbiosystems.com) automated DNA sequencer.
HIV sequence data were analyzed using the software Sequencher
(Genecodes, http://www.genecodes.com). Nucleotide mixtures were
called if the height of the secondary peak exceeded 25% of the height
of the dominant peak. Sequence data were aligned to HIV-1 subtype
B reference strain HXB2 (Genbank accession number K03455) using a
modiﬁed NAP algorithm [40]. HIV subtyping was performed by
comparing HIV sequence data across HIV protease, RT, and Nef to all
known subtype reference sequences in the Los Alamos HIV sequence
database (http://hiv-web.lanl.gov/content/hiv-db/mainpage.html). Of
total participants, 97.5% harbored subtype B infections. Consensus
sequences reﬂecting the most common amino acid at each codon
were generated from pretherapy sequences: these differed from the
2005 HIV-1 subtype B consensus at 1/99 protease, 7/400 RT, 2/96 Vpr,
and 7/206 Nef codons, respectively. Genbank accession numbers of all
unique HIV sequences used in this study are listed in Text S1.
Determination of HLA-A, B, and C genotypes by sequence-based
typing. Sequence-based typing (SBT) for HLA-A, B, and C was
performed on DNA extracted from a PBMC-enriched frozen blood
sample for each participant (n ¼ 765). The SBT protocol is a
validated ‘‘in-house’’ procedure based on International Histocom-
patibility Working Group (IHWG) protocols and involves independ-
ent, locus-speciﬁc, nested PCR ampliﬁcation of exons 2 and 3 of
HLA-A, B, and C followed by automated bidirectional DNA
sequencing. Allele interpretation was performed by comparing SBT
data against all alleles listed in the IMGT/HLA database (ftp://ftp.
ebi.ac.uk/pub/databases/imgt/mhc/hla/) as of August 2005 (Release
2.10). This yields intermediate-to-high level resolution of HLA allele
combinations. In order to achieve appropriately sized groups for
statistical analysis, HLA alleles were summarized to two-digit
resolution; note however that this approach may group together
alleles which bind slightly different peptides, thus potentially
reducing power to detect HLA-associated polymorphisms in some
cases. Ambiguous allele combinations were resolved through
incorporation of published allele frequencies and/or haplotype data.
HLA-A and B typing was completed for all 765 participants, while
HLA-C types were determined for 706 individuals. Although
complete ethnicity data are unavailable, class I allele frequencies
were consistent with those expected in a predominantly North
American white population.
Identiﬁcation of HLA-associated amino acid variation across HIV
genes. In order to discriminate between associations likely attribut-
able to viral lineage effects and those that provide evidence for HLA-
associated escape or reversion, we adopted the phylogenetically
corrected analysis methods described in detail in [16]. Brieﬂy, we used
cohort HIV sequences to construct maximum likelihood phylogenetic
trees (one for each gene). Since HLA types are available only for the
infected individuals sampled, whose sequences form the tips of the
tree, we used a maximum likelihood estimate of the sequence at the
parental (interior) node proximate to each observation, and counted
inferred escape or reversion in these last branches as independent
events to be correlated with the HLA of the infected person at the
terminal sequence by a Fisher exact test (method 1); alternatively, we
used a likelihood ratio test to evaluate whether a model incorporating
the effect of HLA association in addition to the phylogenetic
structure was signiﬁcantly better at explaining the data (method 2)
[16]. The ﬁnal list of identiﬁed associations represents the union of
associations identiﬁed by both methods (Table S1).
In order to adjust for multiple comparisons, a q-value approach
[22], rather than a Bonferroni correction [41], was employed: whereas
a Bonferroni correction attempts to limit the probability of even a
single false positive (and thus increases the rate of false-negative
results), the q-statistic sets the proportion of false positives among
results identiﬁed as signiﬁcant (the false-discovery rate), an approach
which we believe to be more appropriate for gene-wide association
scans such as the present one. Associations with q , 0.2 (indicating a
;20% false-discovery rate) are presented; in this dataset this
corresponded to unadjusted p-values 0.0055 . p . 3.3x10
 45 for all
genes. Note that the results of the lineage-corrected analysis groups
associations into two broad categories based on the direction of the
HLA selection pressure. Positive correlations, in which the presence
of a speciﬁc HLA is associated with the presence of a particular
amino acid—or, correspondingly, where the absence of the allele is
associated with the absence of the amino acid—are termed ‘‘escape’’
associations, as they presumably reﬂect the escape variant for that
speciﬁc HLA allele. Negative correlations, in which the presence of a
speciﬁc HLA allele is associated with the absence of a particular amino
acid—or, correspondingly, where a speciﬁc amino acid is enriched in
the absence of a particular HLA allele—are termed ‘‘reversion’’
associations. In this case, the ‘‘reversion’’ amino acid presumably
reﬂects the immunologically susceptible (‘‘wild-type’’) form speciﬁc
for that HLA allele, as well as represents the amino acid most likely to
re-emerge following transmission to an individual lacking that HLA
allele.
Mapping identiﬁed associations into immune escape maps.
Associations were organized into gene-speciﬁc ‘‘immune escape
maps’’ whose goal was to capture the minimum number of epitopes
(known or putative) required to explain the data. Three sets of escape
maps were generated based on the strength of biological evidence
supporting each association. The highest level of support was granted
to those associations that fell within or proximal to (6 3 aa) a
published HLA-restricted epitope (deﬁned as all HLA class 1-
restricted   1 5 - m e re p i t o p e sl i s t e di nt h eL o sA l a m o sH I V
Immunology database as of December 2006 [23]). HLA-matched
associations that fell within these boundaries were grouped together.
Note that the 6 3 aa proximal ‘‘window’’ was chosen to identify
putative proteasomal processing escape mutations [24–26] based on
evidence indicating that the majority of such mutations occur in the
three amino acids immediately ﬂanking the epitope [42]. The
secondary level of support was granted to associations which fell
within or proximal to a known HLA-restricted epitope anchor
residue motif (using MotifScan, http://hiv-web.lanl.gov/content/
immunology/motif_scan/motif_scan) and/or a putative HLA-re-
stricted epitope identiﬁed by an independently validated CTL
epitope prediction algorithm (Epipred, http://atom.research.
microsoft.com/bio/epipred.aspx [43]) based on scanning the cohort
consensus sequence. Again, associations falling within the ‘‘motif 6 3
aa ﬂanking window’’ were grouped together.
If speciﬁc amino acid variants were associated with additional HLA
alleles in linkage disequilibrium (LD), these alleles were also grouped
together within the epitope or motif. To identify HLA alleles in LD,
we investigated all possible pairwise allele combinations using a
simple Fisher’s exact test and conservatively deﬁned all allele pairs
with p , 0.05 (q , 0.2) as linked (Table S2). In cases where LD allele
pairs were associated with variation at the same codon, the allele
exhibiting the strongest association (as estimated by lowest p-value)
was classiﬁed as the allele driving the association.
To provide in vitro functional support to identiﬁed associations,
we drew upon a partially published ELISpot dataset of 372 HIV-1
infected, non-white individuals screened for HLA-restricted, CTL-
mediated IFN-c responses against set of 410 overlapping subtype B
consensus peptides (OLP) 15 to 20 amino acids in length, spanning
the whole expressed HIV-1 subtype B proteome [27]. Associations
between possession of individual HLA alleles and responses to
speciﬁc consensus peptides in the OLP set [27] were assessed by
simple Fisher exact test. HLA allele/OLP associations with p , 0.05
were considered to be ‘‘signiﬁcantly reactive’’ and thus indicative that
an HLA-restricted CTL epitope lay in the boundaries of that OLP.
HLA-associated polymorphisms identiﬁed in the present study that
mapped directly within an HLA-speciﬁc reactive OLP were identiﬁed
and annotated as ‘‘in vitro-supported’’ on the immune escape maps
(green; Figures 2–5). Note that the differences in ethnic composition
of the current and ELISpot-characterized [27] study populations may
result in an underestimation of in vitro-supported associations, due
to differences in cohort HLA composition and thus power to detect
signiﬁcant associations.
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Figure S1. Illustration of a Case where an Apparent HLA-Associated
HIV Amino Acid Variation Pattern Is an Artifact of the Phylogenetic
Tree, and Using a Phylogenetic Correction Avoids an Incorrect
Assignment of an HLA Driven Association
(A) This is a maximum likelihood tree (for details, please see [16]) of
the complete HIV Nef sequence set, with the inclusion of several
subtyping reference strains from the Los Alamos database. Subtype B
sequences are to the right of the node marked ‘‘B.’’ A small number of
other HIV subtypes were identiﬁed in this cohort, as indicated in the
tree. The amino acid at position 18 is tracked through the tree, with
the most likely amino acid at each ancestral node estimated. Glutamic
acid (E) is the most commonly observed amino acid in this position,
and is indicated in red in the tree. However, a large cluster of
sequences within subtype B has an Aspartic acid (D) at this position,
indicated by gold in the tree (yellow boxed area). There is a paucity of
B14 individuals in this subcluster (indicated by magenta lines), giving
rise to an apparent ‘‘negative’’ association between E and B14. The
apparent statistical signiﬁcance of this association, if one does not
include a correction for the phylogeny, is dominated by this single
subcluster, and is the result of lineage effects, not HLA-mediated
escape or reversion. This is an example of how sub-lineages within a
major subtype can impact association analysis. Based on this type of
analysis, as well as statistical estimates of the frequency of
immunologically validated associations, we decided to include only
phylogenetically corrected associations in this study.
(B) A detail of the yellow boxed area in (A). The probability of a given
amino acid being ‘‘E’’ at an interior node is indicated by a number.
For example, 9 indicates the probability is greater than 0.9. For the
actual sequences at the terminal nodes, this probability is obviously
known and if the amino acid is E, the probability is simple 1.
However, for the sequences at the interior nodes, the probability is
estimated based on the tree topology and evolutionary model. A ‘‘0’’
indicates the probability is less than 0.1 that the amino acid is E, and
the color indicates the most likely amino acid at this position any
given node in the tree.
Found at doi:10.1371/journal.ppat.0030094.sg001 (2.2 MB PDF).
Table S1. Full List of HLA Allele-Associated HIV Polymorphisms in
Functional and Accessory/Regulatory Proteins Investigated
(A) Full list of HLA allele-associated HIV polymorphisms in Nef
(B) Full list of HLA allele-associated HIV polymorphisms in protease,
reverse transcriptase, and VPR
‘‘Escape’’ amino acids indicate amino acids that are enriched in the
presence of a speciﬁc HLA allele, thus presumably reﬂecting the
escape variant speciﬁc for that HLA allele.
‘‘Reversion’’ amino acids indicate amino acids that are enriched in
the absence of a speciﬁc allele (or likewise, depleted in the presence of
a speciﬁc HLA allele). ‘‘Reversion’’ amino acids presumably reﬂect
the immunologically susceptible (‘wild-type’’) form speciﬁc for that
HLA allele, and also represent the amino acid to which the sequence
may revert upon transmission to an individual lacking that HLA
allele.
Found at doi:10.1371/journal.ppat.0030094.st001 (518 KB DOC).
Table S2. Full List of HLA Linkage Disequilibrium Pairs Observed in
Our Dataset (p , 0.05, q , 0.2)
Found at doi:10.1371/journal.ppat.0030094.st002 (30 KB DOC).
Text S1. Accession Numbers
Found at doi:10.1371/journal.ppat.0030094.sd001 (28 KB DOC).
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